Diabetes Core Update is a monthly podcast that presents and discusses the latest clinically relevant articles from the American Diabetes Association’s four science and medical journals – Diabetes, Diabetes Care, Clinical Diabetes, and Diabetes Spectrum. Each episode is approximately 20 minutes long and presents 5-6 recently published articles from ADA journals. Intended for practicing physicians and health care professionals, Diabetes Core Update discusses how the latest research and information published in journals of the American Diabetes Association are relevant to clinical practice and can be applied in a treatment setting. This issue will review: Time in Range and Mortality  Prevalence of Liver Fibrosis in Patients With T2DM  Durability of Triple Combination Therapy Versus Stepwise Addition Therapy in Patients With New- Onset T2DM  Glycemic Control and Risk of Cellulitis  Dapagliflozin and the Incidence of Type 2 Diabetes in Patients With Heart Failure and Reduced Ejection Fraction  Association of Serum 25-Hydroxyvitamin D Concentrations With All-Cause and Cause-Specific Mortality Among Individuals With Diabetes  For more information about each of ADA’s science and medical journals, please visit www.diabetesjournals.org. Presented by: Neil Skolnik, M.D., Professor of Family and Community Medicine, Sidney Kimmel Medical College, Thomas Jefferson University; Associate Director, Family Medicine Residency Program, Abington Jefferson Health John J. Russell, M.D., Professor of Family and Community Medicine, Sidney Kimmel Medical College, Thomas Jefferson University; Director, Family Medicine Residency Program, Chair-Department of Family Medicine, Abington Jefferson Health

In this episode of Practice Pearls: Overcoming Therapeutic Inertia Dr. Andrew Bzowyckyj discusses overcoming resistance to treatment intensification. This is part of the American Diabetes Association’s Overcoming Therapeutic Inertia initiative supported by Strategic Sponsors AstraZeneca and Sanofi, plus Supporting Sponsors Merck and Novo Nordisk. This episode is sponsored by the Overcoming Therapeutic Inertia  Initiative - for more information about resources for overcoming therapeutic inertia, just go to www.TherapeuticInertia.diabetes.org Presented by: Andrew Bzowyckyj, PharmD, BDPS, CDCES, Associate Professor, Pacific University Oregon Neil Skolnik, M.D. , Professor of Family and Community Medicine, Sidney Kimmel Medical College, Thomas Jefferson University, Associate Director, Family Medicine Residency Program, Abington Jefferson Health

In this episode of Practice Pearls: Overcoming Therapeutic Inertia Dr. Eden Miller discusses practical tips for how to effectively facilitate prior authorizations.  This is part of the American Diabetes Association’s Overcoming Therapeutic Inertia initiative supported by Strategic Sponsors AstraZeneca and Sanofi, plus Supporting Sponsors Merck and Novo Nordisk. This episode is sponsored by the Overcoming Therapeutic Inertia  Initiative - for more information about resources for overcoming therapeutic inertia, just go to www.TherapeuticInertia.diabetes.org Presented by: Eden Miller, D.O., High Lakes Health Care, Bend, OR Neil Skolnik, M.D. , Professor of Family and Community Medicine, Sidney Kimmel Medical College, Thomas Jefferson University, Associate Director, Family Medicine Residency Program, Abington Jefferson Health

Diabetes Core Update is a monthly podcast that presents and discusses the latest clinically relevant articles from the American Diabetes Association’s four science and medical journals – Diabetes, Diabetes Care, Clinical Diabetes, and Diabetes Spectrum. Each episode is approximately 20 minutes long and presents 5-6 recently published articles from ADA journals. Intended for practicing physicians and health care professionals, Diabetes Core Update discusses how the latest research and information published in journals of the American Diabetes Association are relevant to clinical practice and can be applied in a treatment setting. This issue will review: Once-Weekly Insulin for Type 2 Diabetes Impact of Bariatric Surgery on Microvascular Complications in Patients With Type 2 Diabetes Sotagliflozin in Patients with Diabetes and Chronic Kidney Disease Worldwide Epidemiology of Diabetes-Related End-Stage Renal Disease, 2000–2015 Sedentary Time and Metabolic Risk in Extremely Active Older Adults Severe Hypoglycemia, Cardiac Structure and Function, and Risk of Cardiovascular Events Among Older Adults With Diabetes For more information about each of ADA’s science and medical journals, please visit www.diabetesjournals.org. Presented by: Neil Skolnik, M.D., Professor of Family and Community Medicine, Sidney Kimmel Medical College, Thomas Jefferson University; Associate Director, Family Medicine Residency Program, Abington Jefferson Health John J. Russell, M.D., Professor of Family and Community Medicine, Sidney Kimmel Medical College, Thomas Jefferson University; Director, Family Medicine Residency Program, Chair-Department of Family Medicine, Abington Jefferson Health

In this episode of Practice Pearls: Overcoming Therapeutic Inertia Drs. Robert Gabbay and Dr. Kamlesh Khunti discuss an overview of Therapeutic Inertia and the American Diabetes Associations initiative on overcoming therapeutic inertia. This is part of the American Diabetes Association’s Overcoming Therapeutic Inertia initiative supported by Strategic Sponsors AstraZeneca and Sanofi, plus Supporting Sponsors Merck and Novo Nordisk. This episode is sponsored by the Overcoming Therapeutic Inertia  Initiative - for more information about resources for overcoming therapeutic inertia, just go to www.TherapeuticInertia.diabetes.org .  Presented by: Robert Gabbay, MD, PhD, FACP, Chief Scientific and Medical Officer, American Diabetes Association Kamlesh Khunti, MD, PhD, Professor of Primary Care Diabetes & Vascular Medicine, University of Leicester, Leicester General Hospital, Leicester, UK Neil Skolnik, M.D. , Professor of Family and Community Medicine, Sidney Kimmel Medical College, Thomas Jefferson University, Associate Director, Family Medicine Residency Program, Abington Jefferson Health

In this third episode of the three-part series “Influenza and Diabetes,” Drs. John Russell and Neil Skolnik discuss frequently asked questions about diabetes, heart disease, the effects of influenza and the impact of influenza vaccination. They also discuss the details of currently available vaccine choices and strategies to enhance vaccination rates.  This special three-part series is supported by independent educational grant from Sanofi Pasteur. For more information about each of ADA’s science and medical journals, please visit www.diabetesjournals.org. Presented by: Neil Skolnik, M.D., Professor of Family and Community Medicine, Sidney Kimmel Medical College, Thomas Jefferson University; Associate Director, Family Medicine Residency Program, Abington Jefferson Health John J. Russell, M.D., Professor of Family and Community Medicine, Sidney Kimmel Medical College, Thomas Jefferson University; Director, Family Medicine Residency Program, Chair-Department of Family Medicine, Abington Jefferson Health

In this second episode of a three-part series on SGLT-2 inhibitors Drs. John Russell and Neil Skolnik discuss the renal effects of the SGLT-2 inhibitors, as well as the place of the SGLT-2is in the American Diabetes Association Guidelines and address practical issues about SGLT-2 inhibitor use.  In episode 1, Drs. Russell and Skolnik discussed an overview of the CVOTs for the SGLT-2 inhibitors and in episode 3 they will focus heart failure outcomes.  This special three-part series is supported by independent educational grant from AstraZeneca. For more information about each of ADA’s science and medical journals, please visit www.diabetesjournals.org. Presented by: Neil Skolnik, M.D., Professor of Family and Community Medicine, Sidney Kimmel Medical College, Thomas Jefferson University; Associate Director, Family Medicine Residency Program, Abington Jefferson Health John J. Russell, M.D., Professor of Family and Community Medicine, Sidney Kimmel Medical College, Thomas Jefferson University; Director, Family Medicine Residency Program, Chair-Department of Family Medicine, Abington Jefferson Health

Diabetes Core Update is a monthly podcast that presents and discusses the latest clinically relevant articles from the American Diabetes Association’s four science and medical journals – Diabetes, Diabetes Care, Clinical Diabetes, and Diabetes Spectrum. Each episode is approximately 20 minutes long and presents 5-6 recently published articles from ADA journals. Intended for practicing physicians and health care professionals, Diabetes Core Update discusses how the latest research and information published in journals of the American Diabetes Association are relevant to clinical practice and can be applied in a treatment setting. This issue will review: Cardiovascular and Renal Outcomes with Empagliflozin in Heart Failure Impact of Comorbidities and Glycemia at Admission and DPP-4 Inhibitors in Patients With Type 2 Diabetes With COVID-19 Diabetes as a Risk Factor for Poor Early Outcomes in Patients Hospitalized With COVID-19 Changes in Statin Use Among U.S. Adults With Diabetes Dapagliflozin in Patients with Chronic Kidney Disease Study For more information about each of ADA’s science and medical journals, please visit www.diabetesjournals.org. Presented by: Neil Skolnik, M.D., Professor of Family and Community Medicine, Sidney Kimmel Medical College, Thomas Jefferson University; Associate Director, Family Medicine Residency Program, Abington Jefferson Health John J. Russell, M.D., Professor of Family and Community Medicine, Sidney Kimmel Medical College, Thomas Jefferson University; Director, Family Medicine Residency Program, Chair-Department of Family Medicine, Abington Jefferson Health

This special issue focuses on inpatient management of People with Diabetes and COVID-19 answering questions from a large online audience as a launching point for discussion.   Recorded Oct 13, 2020 This is a part of the American Diabetes Associations ongoing project providing resources for practicing clinicians on the care of Diabetes during the Covid-19 pandemic.  Today’s discussion is an audio version of a webinar recorded on May 14, 2020. Presented by: Robert A. Gabbay, MD, PhD American Diabetes Association Joseph A. Aloi, MD Wake Forest Baptist Health Amisha Wallia, MD Northwestern Memorial Hospital Rodolfo Galindo, MD Emory University

Diabetes Core Update: Therapeutic Inertia Part 3 – November 2020 In this third episode of a three-part series on “Disrupting Therapeutic Inertia in Diabetes Management,” we discuss practical advice about how to combat therapeutic inertia in the office with four clinical experts.  This special three-part series on therapeutic inertia is supported by independent educational grant from Sanofi (https://www.sanofi.com). For more information about each of ADA’s science and medical journals, please visit www.diabetesjournals.org. Presented by: Neil Skolnik, M.D., Professor of Family and Community Medicine, Sidney Kimmel Medical College, Thomas Jefferson University; Associate Director, Family Medicine Residency Program, Abington Jefferson Health Eric Johnson, M.D., Professor and Director of Interprofessional Education, Office of Interprofessional Education, Department of Education Resources, School of Medicine and Health Sciences, Grand Forks, ND; Chair-Primary Care Advisory Group, American Diabetes Association William H. Polonsky, PhD, CDCES , President - Behavioral Diabetes Institute,  Associate Clinical Professor,  University of California, San Diego Pam Kushner, M.D. , Clinical Professor of Family Medicine, University of California at Irvine. Steve Edelman, M.D. , Professor of Medicine at the University of California, San Diego  and Founder of “Taking control of Your Diabetes”.